West Milford, NJ, United States of America

Jack Martin Lipman

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Jack Martin Lipman

Introduction

Jack Martin Lipman is a notable inventor based in West Milford, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in pain management. With a total of five patents to his name, Lipman's work focuses on innovative drug formulations that aim to improve patient outcomes.

Latest Patents

Lipman's latest patents include groundbreaking formulations for treating pain. One of his notable inventions is a fixed-dose combination drug that comprises a non-steroidal anti-inflammatory drug (NSAID) as the first component and a GABA-type calcium channel blocker as the second component. This combination is designed to enhance pain relief while minimizing side effects. Another significant patent involves acetaminophen and pregabalin combinations, which present methods for an injectable liquid formulation. This formulation aims to reduce the need for postoperative analgesics, thereby improving the recovery experience for patients.

Career Highlights

Throughout his career, Lipman has worked with prominent companies in the pharmaceutical industry, including Nevakar Inc. and Nevakar Injectables Inc. His expertise in drug formulation and pain management has positioned him as a valuable asset in these organizations.

Collaborations

Lipman has collaborated with several professionals in his field, including Tushar Hingorani and Kumaresh Soppimath. These collaborations have contributed to the development of innovative solutions in pain management.

Conclusion

Jack Martin Lipman's contributions to pharmaceutical innovations, particularly in pain management, highlight his dedication to improving patient care. His patents reflect a commitment to developing effective and safe drug formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…